Clinical Trial Update: Topical Amitriptyline 1% Gel for the Treatment of Burning Mouth Syndrome

View source ↗

Summary

A clinical trial evaluating topical amitriptyline 1% gel for Burning Mouth Syndrome (stomatodynia) has completed. The update does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burning Mouth Syndrome
• Stomatodynia

Drugs mentioned

• amitriptyline 1% gel (amitriptyline)

Snippet

Sponsor: Universidad de Murcia | Conditions: Burning Mouth Syndrome, Stomatodynia | Status: COMPLETED